These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 24460140

  • 1. Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
    Therese PJ, Manvar D, Kondepudi S, Battu MB, Sriram D, Basu A, Yogeeswari P, Kaushik-Basu N.
    J Chem Inf Model; 2014 Feb 24; 54(2):539-52. PubMed ID: 24460140
    [Abstract] [Full Text] [Related]

  • 2. Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors.
    Musmuca I, Caroli A, Mai A, Kaushik-Basu N, Arora P, Ragno R.
    J Chem Inf Model; 2010 Apr 26; 50(4):662-76. PubMed ID: 20225870
    [Abstract] [Full Text] [Related]

  • 3. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
    Wei Y, Li J, Qing J, Huang M, Wu M, Gao F, Li D, Hong Z, Kong L, Huang W, Lin J.
    PLoS One; 2016 Apr 26; 11(2):e0148181. PubMed ID: 26845440
    [Abstract] [Full Text] [Related]

  • 4. Searching for anthranilic acid-based thumb pocket 2 HCV NS5B polymerase inhibitors through a combination of molecular docking, 3D-QSAR and virtual screening.
    Vrontaki E, Melagraki G, Mavromoustakos T, Afantitis A.
    J Enzyme Inhib Med Chem; 2016 Apr 26; 31(1):38-52. PubMed ID: 26060939
    [Abstract] [Full Text] [Related]

  • 5. Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.
    Harikishore A, Li E, Lee JJ, Cho NJ, Yoon HS.
    Mol Divers; 2015 Aug 26; 19(3):529-39. PubMed ID: 25862642
    [Abstract] [Full Text] [Related]

  • 6. Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.
    Elhefnawi M, ElGamacy M, Fares M.
    BMC Bioinformatics; 2012 Aug 26; 13 Suppl 17(Suppl 17):S5. PubMed ID: 23282180
    [Abstract] [Full Text] [Related]

  • 7. Combined 3D-QSAR, molecular docking, molecular dynamics simulation, and binding free energy calculation studies on the 5-hydroxy-2H-pyridazin-3-one derivatives as HCV NS5B polymerase inhibitors.
    Yu H, Fang Y, Lu X, Liu Y, Zhang H.
    Chem Biol Drug Des; 2014 Jan 26; 83(1):89-105. PubMed ID: 23941500
    [Abstract] [Full Text] [Related]

  • 8. Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation.
    Ryu K, Kim ND, Choi SI, Han CK, Yoon JH, No KT, Kim KH, Seong BL.
    Bioorg Med Chem; 2009 Apr 15; 17(8):2975-82. PubMed ID: 19332375
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking Study.
    Elfiky AA.
    Med Chem; 2019 Apr 15; 15(2):130-137. PubMed ID: 30324891
    [Abstract] [Full Text] [Related]

  • 11. Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.
    Zhang HX, Li Y, Wang X, Xiao ZT, Wang YH.
    Curr Med Chem; 2011 Apr 15; 18(26):4019-28. PubMed ID: 21824089
    [Abstract] [Full Text] [Related]

  • 12. Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR.
    El-Hassab MAE, El-Bastawissy EE, El-Moselhy TF.
    J Biomol Struct Dyn; 2020 Sep 15; 38(15):4521-4535. PubMed ID: 31647392
    [Abstract] [Full Text] [Related]

  • 13. Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Çakir G, Küçükgüzel İ, Guhamazumder R, Tatar E, Manvar D, Basu A, Patel BA, Zia J, Talele TT, Kaushik-Basu N.
    Arch Pharm (Weinheim); 2015 Jan 15; 348(1):10-22. PubMed ID: 25449674
    [Abstract] [Full Text] [Related]

  • 14. Large-scale structure-activity relationship study of hepatitis C virus NS5B polymerase inhibition using SMILES-based descriptors.
    Worachartcheewan A, Prachayasittikul V, Toropova AP, Toropov AA, Nantasenamat C.
    Mol Divers; 2015 Nov 15; 19(4):955-64. PubMed ID: 26164590
    [Abstract] [Full Text] [Related]

  • 15. 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase.
    Küçükgüzel I, Satılmış G, Gurukumar KR, Basu A, Tatar E, Nichols DB, Talele TT, Kaushik-Basu N.
    Eur J Med Chem; 2013 Nov 15; 69():931-41. PubMed ID: 24161679
    [Abstract] [Full Text] [Related]

  • 16. Screening and molecular docking of selected phytochemicals against NS5B polymerase of hepatitis c virus.
    Mustafa G, Majid M, Ghaffar A, Yameen M, Samad HA, Mahrosh HS.
    Pak J Pharm Sci; 2020 Sep 15; 33(5(Supplementary)):2317-2322. PubMed ID: 33832906
    [Abstract] [Full Text] [Related]

  • 17. A highly selective structure-based virtual screening model of Palm I allosteric inhibitors of HCV Ns5b polymerase enzyme and its application in the discovery and optimization of new analogues.
    Mahmoud AH, Abou El Ella DA, Ismail MA, Abouzid KA.
    Eur J Med Chem; 2012 Nov 15; 57():468-82. PubMed ID: 22824204
    [Abstract] [Full Text] [Related]

  • 18. Discovery of novel HCV polymerase inhibitors using pharmacophore-based virtual screening.
    Kim ND, Chun H, Park SJ, Yang JW, Kim JW, Ahn SK.
    Bioorg Med Chem Lett; 2011 Jun 01; 21(11):3329-34. PubMed ID: 21531135
    [Abstract] [Full Text] [Related]

  • 19. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
    Patel PD, Patel MR, Kaushik-Basu N, Talele TT.
    J Chem Inf Model; 2008 Jan 01; 48(1):42-55. PubMed ID: 18076152
    [Abstract] [Full Text] [Related]

  • 20. Non-nucleoside inhibitors of NS5B polymerase binding to allosteric sites: 3D- QSAR and molecular docking studies.
    Cao H, Cao R, Zhang H, Zheng X, Gao D.
    Curr Med Chem; 2008 Jan 01; 15(15):1462-77. PubMed ID: 18537623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.